Safety of multicomponent meningococcal group B vaccine
- Author
- The Lancet
- Published
- Thu 26 Apr 2018
- Episode Link
- None
Philip Bryan joins The Lancet Child & Adolescent Health to discuss the safety of multicomponent meningococcal group B vaccine (4CMenB) in the UK’s infant immunisation programme.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://www.linkedin.com/company/lanchi/
https://youtube.com/thelancettv
